English

HELICOS BIOSCIENCES CORP

EDGAR

Quarterly report (10-Q) · filed 2012-08-14

27 filing records in this dataset, filed from 2007-08-08 to 2012-08-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

577 thousand USD

2012 Q2 · USD

Exact inputs and evidence

Revenue: 577000 USD Source

Operating margin

-174.7%

2012 Q2 · %

Exact inputs and evidence

Operating Income: -1008000 USD Source
Revenue: 577000 USD Source

Operating cash flow

316 thousand USD

2012 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 134000 USD Source
Operating Cash Flow: -182000 USD Source

Free cash flow

316 thousand USD

2012 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 134000 USD Source
Operating Cash Flow: -182000 USD Source
Capital Expenditure: 0 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 446 thousand USD 2012-06-30 Source
Exact value

446000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 87 million shares 2012-06-30 Source
Exact value

87032882 shares

Reported share-count change

-0.45% · -395 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

87428037 shares · 2011-06-30· Source
87032882 shares · 2012-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

2.37 million USD

2011-07-01 – 2012-06-30

Exact inputs and evidence

Revenue: 725000 USD · 2011-07-01 – 2011-09-30 Source
Revenue: 3230000 USD · 2011-01-01 – 2011-12-31 Source
Revenue: 2716000 USD · 2011-01-01 – 2011-09-30 Source
Revenue: 551000 USD · 2012-01-01 – 2012-03-31 Source
Revenue: 577000 USD · 2012-04-01 – 2012-06-30 Source

Net income

-5.03 million USD

2011-07-01 – 2012-06-30

Exact inputs and evidence

Net income: -798000 USD · 2011-07-01 – 2011-09-30 Source
Net income: -5825000 USD · 2011-01-01 – 2011-12-31 Source
Net income: -2973000 USD · 2011-01-01 – 2011-09-30 Source
Net income: -922000 USD · 2012-01-01 – 2012-03-31 Source
Net income: -459000 USD · 2012-04-01 – 2012-06-30 Source

Operating cash flow

-400 thousand USD

2011-07-01 – 2012-06-30

Exact inputs and evidence

Operating cash flow: -821000 USD · 2011-01-01 – 2011-09-30 Source
Operating cash flow: -407000 USD · 2011-01-01 – 2011-06-30 Source
Operating cash flow: -941000 USD · 2011-01-01 – 2011-12-31 Source
Operating cash flow: -821000 USD · 2011-01-01 – 2011-09-30 Source
Operating cash flow: -182000 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: 134000 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: -182000 USD · 2012-01-01 – 2012-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-08-14.

Financial data available through: 2011-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2011-12-31
Operating income: 7 of 11 periods available· newest 2011-12-31
Net income: 7 of 11 periods available· newest 2011-12-31
Operating cash flow: 6 of 11 periods available· newest 2011-12-31
Capital expenditure: 5 of 11 periods available· newest 2010-12-31
Total assets: 6 of 11 periods available· newest 2011-12-31
Total liabilities: 6 of 11 periods available· newest 2011-12-31
Current assets: 6 of 11 periods available· newest 2011-12-31
Current liabilities: 6 of 11 periods available· newest 2011-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2011-12-31
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2011-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-26.5%

Prior period

USD 4.4 million

2010-01-01 – 2010-12-31
Current period

USD 3.23 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

3230000 − 4397000 = -1167000 USD

4397000 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
3230000 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · HELICOS BIOSCIENCES CORP · 2011-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Year-over-year change in Revenue: -1167000 USD Concept: fundies:Revenue Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 3230000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#63906 Filing: 000104746912003686 Input fundies:Revenue: 4397000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#65864 Filing: 000104746912003686
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 12.94 million

Prior period

−USD 18.77 million

2010-01-01 – 2010-12-31
Current period

−USD 5.83 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

-5825000 − -18768000 = 12943000 USD

-18768000 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
-5825000 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · HELICOS BIOSCIENCES CORP · 2011-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Year-over-year change in Net income: 12943000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -5825000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#62704 Filing: 000104746912003686 Input fundies:NetIncome: -18768000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#47315 Filing: 000104746912003686
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 11.03 million

Prior period

−USD 11.97 million

2010-01-01 – 2010-12-31
Current period

−USD 941,000

2011-01-01 – 2011-12-31

Exact inputs and evidence

-941000 − -11967000 = 11026000 USD

-11967000 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
-941000 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · HELICOS BIOSCIENCES CORP · 2011-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Year-over-year change in Operating cash flow: 11026000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -941000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#60979 Filing: 000104746912003686 Input fundies:OperatingCashFlow: -11967000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#84847 Filing: 000104746912003686
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2011 2011-01-01 – 2011-12-31

Revenue USD 3.23 million 100% of revenue
Cost of revenue USD 224,000 6.9% of revenue
Operating expenses USD 9.05 million 280% of revenue
Operating income −USD 6.05 million −187% of revenue
Tax, interest and other Derived −USD 223,000 −6.9% of revenue
Net income −USD 5.83 million −180% of revenue

Cash

Operating cash flow −USD 941,000 −29% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2006 Operating loss: operating costs were 13,396% of revenue.
2007 Operating loss: operating costs were 6,713% of revenue.
2008 Operating loss: operating costs were 5,540% of revenue.
2009 Operating loss: operating costs were 1,057% of revenue.
2010 Operating loss: operating costs were 618% of revenue.
2011 Operating loss: operating costs were 287% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2006 2006-01-01 – 2006-12-31	159000	21299000 Derived	-21140000	-560000 Derived	-20580000	-19285000 Derived	Source 2006-01-01 – 2006-12-31: 159000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -21140000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -20580000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -16532000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 2753000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	582000	39070000 Derived	-38488000	-1683000 Derived	-36805000	-34986000 Derived	Source 2007-01-01 – 2007-12-31: 582000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -38488000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -36805000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -32803000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 2183000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	808000	44764000 Derived	-43956000	1695000 Derived	-45651000	-47190000 Derived	Source 2008-01-01 – 2008-12-31: 808000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -43956000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -45651000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -44301000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 2889000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	3026000	31976000 Derived	-28950000	-990000 Derived	-27960000	-15510000 Derived	Source 2009-01-01 – 2009-12-31: 3026000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -28950000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -27960000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -15488000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 22000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	4397000	27160000 Derived	-22763000	-3995000 Derived	-18768000	-11994000 Derived	Source 2010-01-01 – 2010-12-31: 4397000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -22763000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -18768000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -11967000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 27000 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	3230000	9278000 Derived	-6048000	-223000 Derived	-5825000	Unavailable	Source 2011-01-01 – 2011-12-31: 3230000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -6048000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -5825000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -941000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 3.2M 2011

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Revenue	159000	Revenue: 159000 Open source
20072007-12-31	Revenue	582000	Revenue: 582000 Open source
20082008-12-31	Revenue	808000	Revenue: 808000 Open source
20092009-12-31	Revenue	3026000	Revenue: 3026000 Open source
20102010-12-31	Revenue	4397000	Revenue: 4397000 Open source
20112011-12-31	Revenue	3230000	Revenue: 3230000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-26.5% 2011

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Year over year	No prior comparable period	Revenue: 159000 Open source
20072007-12-31	Year over year	266%	Revenue: 582000 Open source Revenue: 159000 Open source
20082008-12-31	Year over year	38.8%	Revenue: 808000 Open source Revenue: 582000 Open source
20092009-12-31	Year over year	274.5%	Revenue: 3026000 Open source Revenue: 808000 Open source
20102010-12-31	Year over year	45.3%	Revenue: 4397000 Open source Revenue: 3026000 Open source
20112011-12-31	Year over year	-26.5%	Revenue: 3230000 Open source Revenue: 4397000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -187.2% 2011

Net margin -180.3% 2011

Free cash flow margin -272.8% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Operating margin	-13,295.6%	Operating Income: -21140000 Open source Revenue: 159000 Open source
20072007-12-31	Operating margin	-6,613.1%	Operating Income: -38488000 Open source Revenue: 582000 Open source
20082008-12-31	Operating margin	-5,440.1%	Operating Income: -43956000 Open source Revenue: 808000 Open source
20092009-12-31	Operating margin	-956.7%	Operating Income: -28950000 Open source Revenue: 3026000 Open source
20102010-12-31	Operating margin	-517.7%	Operating Income: -22763000 Open source Revenue: 4397000 Open source
20112011-12-31	Operating margin	-187.2%	Operating Income: -6048000 Open source Revenue: 3230000 Open source
20062006-12-31	Net margin	-12,943.4%	Net Income: -20580000 Open source Revenue: 159000 Open source
20072007-12-31	Net margin	-6,323.9%	Net Income: -36805000 Open source Revenue: 582000 Open source
20082008-12-31	Net margin	-5,649.9%	Net Income: -45651000 Open source Revenue: 808000 Open source
20092009-12-31	Net margin	-924%	Net Income: -27960000 Open source Revenue: 3026000 Open source
20102010-12-31	Net margin	-426.8%	Net Income: -18768000 Open source Revenue: 4397000 Open source
20112011-12-31	Net margin	-180.3%	Net Income: -5825000 Open source Revenue: 3230000 Open source
20062006-12-31	Free cash flow margin	-12,128.9%	Revenue: 159000 Open source Operating Cash Flow: -16532000 Open source Capital Expenditure: 2753000 Open source
20072007-12-31	Free cash flow margin	-6,011.3%	Revenue: 582000 Open source Operating Cash Flow: -32803000 Open source Capital Expenditure: 2183000 Open source
20082008-12-31	Free cash flow margin	-5,840.3%	Revenue: 808000 Open source Operating Cash Flow: -44301000 Open source Capital Expenditure: 2889000 Open source
20092009-12-31	Free cash flow margin	-512.6%	Revenue: 3026000 Open source Operating Cash Flow: -15488000 Open source Capital Expenditure: 22000 Open source
20102010-12-31	Free cash flow margin	-272.8%	Revenue: 4397000 Open source Operating Cash Flow: -11967000 Open source Capital Expenditure: 27000 Open source
20112011-12-31	Free cash flow margin	Not reported	Revenue: 3230000 Open source Operating Cash Flow: -941000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -941K 2011

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Operating cash flow	-16532000	Operating Cash Flow: -16532000 Open source
20072007-12-31	Operating cash flow	-32803000	Operating Cash Flow: -32803000 Open source
20082008-12-31	Operating cash flow	-44301000	Operating Cash Flow: -44301000 Open source
20092009-12-31	Operating cash flow	-15488000	Operating Cash Flow: -15488000 Open source
20102010-12-31	Operating cash flow	-11967000	Operating Cash Flow: -11967000 Open source
20112011-12-31	Operating cash flow	-941000	Operating Cash Flow: -941000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -12M 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Free cash flow	-19285000	Operating Cash Flow: -16532000 Open source Capital Expenditure: 2753000 Open source
20072007-12-31	Free cash flow	-34986000	Operating Cash Flow: -32803000 Open source Capital Expenditure: 2183000 Open source
20082008-12-31	Free cash flow	-47190000	Operating Cash Flow: -44301000 Open source Capital Expenditure: 2889000 Open source
20092009-12-31	Free cash flow	-15510000	Operating Cash Flow: -15488000 Open source Capital Expenditure: 22000 Open source
20102010-12-31	Free cash flow	-11994000	Operating Cash Flow: -11967000 Open source Capital Expenditure: 27000 Open source
20112011-12-31	Free cash flow	Unavailable	Operating Cash Flow: -941000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

526.6% 2011

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Liabilities / assets	38.4%	Total Liabilities: 5878000 Open source Total Assets: 15300000 Open source
20072007-12-31	Liabilities / assets	26.6%	Total Liabilities: 15770000 Open source Total Assets: 59209000 Open source
20082008-12-31	Liabilities / assets	34.8%	Total Liabilities: 10957000 Open source Total Assets: 31460000 Open source
20092009-12-31	Liabilities / assets	78.6%	Total Liabilities: 20849000 Open source Total Assets: 26535000 Open source
20102010-12-31	Liabilities / assets	188%	Total Liabilities: 13169000 Open source Total Assets: 7003000 Open source
20112011-12-31	Liabilities / assets	526.6%	Total Liabilities: 13503000 Open source Total Assets: 2564000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.18× 2011

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Current assets / current liabilities	3.57×	Current Assets: 12045000 Open source Current Liabilities: 3376000 Open source
20072007-12-31	Current assets / current liabilities	11.8×	Current Assets: 55118000 Open source Current Liabilities: 4672000 Open source
20082008-12-31	Current assets / current liabilities	4.26×	Current Assets: 27206000 Open source Current Liabilities: 6387000 Open source
20092009-12-31	Current assets / current liabilities	1.87×	Current Assets: 24525000 Open source Current Liabilities: 13115000 Open source
20102010-12-31	Current assets / current liabilities	0.55×	Current Assets: 6725000 Open source Current Liabilities: 12275000 Open source
20112011-12-31	Current assets / current liabilities	0.18×	Current Assets: 2455000 Open source Current Liabilities: 13478000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2005 2005-01-01 – 2005-12-31	−USD 10.92 million Exact value Exact value: -10918000 USD 2005-01-01 – 2005-12-31: -10918000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELICOS BIOSCIENCES CORP · 2005-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Net Income: -10918000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10918000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-08-002956.txt#5735 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	−USD 20.58 million Exact value Exact value: -20580000 USD 2006-01-01 – 2006-12-31: -20580000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELICOS BIOSCIENCES CORP · 2006-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Net Income: -20580000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20580000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-09-003424.txt#9912 The citation records this snapshot. The page link may show a newer release later.	−USD 16.53 million Exact value Exact value: -16532000 USD 2006-01-01 – 2006-12-31: -16532000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELICOS BIOSCIENCES CORP · 2006-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Operating Cash Flow: -16532000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16532000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-09-003424.txt#10210 The citation records this snapshot. The page link may show a newer release later.	USD 2.75 million Exact value Exact value: 2753000 USD 2006-01-01 – 2006-12-31: 2753000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HELICOS BIOSCIENCES CORP · 2006-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Capital Expenditure: 2753000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2753000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-09-003424.txt#10256 The citation records this snapshot. The page link may show a newer release later.	−USD 19.29 million Calculation and evidence -16532000 − 2753000 USD Exact free cash flow: -19285000 USD 2006-01-01 – 2006-12-31: -16532000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 2753000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HELICOS BIOSCIENCES CORP · 2006-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Free cash flow: -19285000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16532000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-09-003424.txt#10210 Input fundies:CapitalExpenditure: 2753000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-09-003424.txt#10256 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 36.81 million Exact value Exact value: -36805000 USD 2007-01-01 – 2007-12-31: -36805000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELICOS BIOSCIENCES CORP · 2007-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Net Income: -36805000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -36805000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-10-003781.txt#11413 The citation records this snapshot. The page link may show a newer release later.	−USD 32.8 million Exact value Exact value: -32803000 USD 2007-01-01 – 2007-12-31: -32803000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELICOS BIOSCIENCES CORP · 2007-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Operating Cash Flow: -32803000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32803000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-10-003781.txt#11762 The citation records this snapshot. The page link may show a newer release later.	USD 2.18 million Exact value Exact value: 2183000 USD 2007-01-01 – 2007-12-31: 2183000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HELICOS BIOSCIENCES CORP · 2007-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Capital Expenditure: 2183000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2183000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-10-003781.txt#11808 The citation records this snapshot. The page link may show a newer release later.	−USD 34.99 million Calculation and evidence -32803000 − 2183000 USD Exact free cash flow: -34986000 USD 2007-01-01 – 2007-12-31: -32803000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 2183000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HELICOS BIOSCIENCES CORP · 2007-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Free cash flow: -34986000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32803000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-10-003781.txt#11762 Input fundies:CapitalExpenditure: 2183000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-10-003781.txt#11808 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 45.65 million Exact value Exact value: -45651000 USD 2008-01-01 – 2008-12-31: -45651000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELICOS BIOSCIENCES CORP · 2008-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Net Income: -45651000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -45651000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-11-003014.txt#12109 The citation records this snapshot. The page link may show a newer release later.	−USD 44.3 million Exact value Exact value: -44301000 USD 2008-01-01 – 2008-12-31: -44301000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELICOS BIOSCIENCES CORP · 2008-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Operating Cash Flow: -44301000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -44301000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-11-003014.txt#12475 The citation records this snapshot. The page link may show a newer release later.	USD 2.89 million Exact value Exact value: 2889000 USD 2008-01-01 – 2008-12-31: 2889000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HELICOS BIOSCIENCES CORP · 2008-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Capital Expenditure: 2889000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2889000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-11-003014.txt#12521 The citation records this snapshot. The page link may show a newer release later.	−USD 47.19 million Calculation and evidence -44301000 − 2889000 USD Exact free cash flow: -47190000 USD 2008-01-01 – 2008-12-31: -44301000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 2889000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HELICOS BIOSCIENCES CORP · 2008-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Free cash flow: -47190000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -44301000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-11-003014.txt#12475 Input fundies:CapitalExpenditure: 2889000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/0001047469-11-003014.txt#12521 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 27.96 million Exact value Exact value: -27960000 USD 2009-01-01 – 2009-12-31: -27960000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELICOS BIOSCIENCES CORP · 2009-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Net Income: -27960000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -27960000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#52623 Filing: 000104746912003686 The citation records this snapshot. The page link may show a newer release later.	−USD 15.49 million Exact value Exact value: -15488000 USD 2009-01-01 – 2009-12-31: -15488000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELICOS BIOSCIENCES CORP · 2009-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Operating Cash Flow: -15488000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15488000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#49705 Filing: 000104746912003686 The citation records this snapshot. The page link may show a newer release later.	USD 22,000 Exact value Exact value: 22000 USD 2009-01-01 – 2009-12-31: 22000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HELICOS BIOSCIENCES CORP · 2009-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Capital Expenditure: 22000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 22000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#49534 Filing: 000104746912003686 The citation records this snapshot. The page link may show a newer release later.	−USD 15.51 million Calculation and evidence -15488000 − 22000 USD Exact free cash flow: -15510000 USD 2009-01-01 – 2009-12-31: -15488000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 22000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HELICOS BIOSCIENCES CORP · 2009-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Free cash flow: -15510000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15488000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#49705 Filing: 000104746912003686 Input fundies:CapitalExpenditure: 22000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#49534 Filing: 000104746912003686 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 18.77 million Exact value Exact value: -18768000 USD 2010-01-01 – 2010-12-31: -18768000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELICOS BIOSCIENCES CORP · 2010-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Net Income: -18768000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18768000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#47315 Filing: 000104746912003686 The citation records this snapshot. The page link may show a newer release later.	−USD 11.97 million Exact value Exact value: -11967000 USD 2010-01-01 – 2010-12-31: -11967000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELICOS BIOSCIENCES CORP · 2010-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Operating Cash Flow: -11967000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11967000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#84847 Filing: 000104746912003686 The citation records this snapshot. The page link may show a newer release later.	USD 27,000 Exact value Exact value: 27000 USD 2010-01-01 – 2010-12-31: 27000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HELICOS BIOSCIENCES CORP · 2010-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Capital Expenditure: 27000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 27000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#84675 Filing: 000104746912003686 The citation records this snapshot. The page link may show a newer release later.	−USD 11.99 million Calculation and evidence -11967000 − 27000 USD Exact free cash flow: -11994000 USD 2010-01-01 – 2010-12-31: -11967000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 27000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HELICOS BIOSCIENCES CORP · 2010-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Free cash flow: -11994000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11967000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#84847 Filing: 000104746912003686 Input fundies:CapitalExpenditure: 27000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#84675 Filing: 000104746912003686 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 5.83 million Exact value Exact value: -5825000 USD 2011-01-01 – 2011-12-31: -5825000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HELICOS BIOSCIENCES CORP · 2011-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Net Income: -5825000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5825000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#62704 Filing: 000104746912003686 The citation records this snapshot. The page link may show a newer release later.	−USD 941,000 Exact value Exact value: -941000 USD 2011-01-01 – 2011-12-31: -941000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HELICOS BIOSCIENCES CORP · 2011-12-31 HELICOS BIOSCIENCES CORP (edgar:1274563) Operating Cash Flow: -941000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:06:25Z Snapshot: c62eaa9f340368c755b209861273ef5b41fa15ccd606154a589c867038b99ffe Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274563/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -941000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274563/000104746912003686/hlcs-20111231.xml#60979 Filing: 000104746912003686 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

27 filings · 686 latest values · 686 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001274563, 1274563, edgar:1274563

Also known as HELICOS BIOSCIENCES CORP

HELICOS BIOSCIENCES CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2011 2011-01-01 – 2011-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation